deltatrials
Available EXPANDED_ACCESS NCT05041036

Individual Patient Compassionate Use of Nirogacestat

Sponsor: SpringWorks Therapeutics, Inc.

Updated 5 times since 2021 Last updated: Mar 13, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Desmoid Tumor and NOTCH Gene Mutation Positive Tumors, this trial is ongoing. The trial is conducted by SpringWorks Therapeutics, Inc. and has accumulated 5 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Oct 2021 – ~Sep 2023 · 23 months · monthly snapshotAvailable~Sep 2023 – ~Apr 2024 · 7 months · monthly snapshotAvailable~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotAvailable

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Available

  2. Jul 2024 — Sep 2024 [monthly]

    Available

  3. Apr 2024 — Jul 2024 [monthly]

    Available

  4. Sep 2023 — Apr 2024 [monthly]

    Available

  5. Oct 2021 — Sep 2023 [monthly]

    Available

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • SpringWorks Therapeutics, Inc.
Data source: SpringWorks Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.